Sign In
9 Nov 2012 07:00
Regenersis Plc
("Regenersis" or "the Company")
Directors' Share Dealings
The Company received notification on 8 November 2012 that Michael Peacock, a Non-executive Director of Regenersis, acquired 3,000 ordinary shares in the Company on 8 November 2012 at a price of 150p per share.
Following this acquisition, Michael Peacock has a beneficial interest of 3,000 Ordinary shares, representing 0.01 % of the Company's issued share capital.
-ends-
For further information, please contact:
Regenersis Plc Matthew Peacock, Executive Chairman Jog Dhody, Chief Financial Officer
| +44 (0) 20 7657 7000 |
Arden Partners plc (Nomad and Joint Broker) Steve Douglas
| +44 (0) 121 423 8900 |
Panmure Gordon (UK) Limited (Joint Broker) Dominic Morley / Charles Leigh-Pemberton
| +44 (0) 20 7886 2500 |
Tavistock Communications Catriona Valentine / Matt Ridsdale / Keeley Clarke
| +44 (0) 20 7920 3150 |
BLTG.L (BLTG)
Follow the stocks
